• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Dr. Niteesh Choudhry Discusses Value-Based Insurance Design [Part 1 of 4]

Article

Dr. Niteesh Choudhry, Associate Professor, Harvard Medical School, Division of Pharmacoepidemiology and Pharmacoeconomics in Boston, discusses VBID and how looming questions revealed from this study show the model’s importance as well as its need to be better defined.

Dr. Choudhry explains that a key method to better defining VBID is to conduct similar studies within other specialties to learn about outcomes when the model is applied to diseases such as diabetes, hypertension, and hyperlipidemia.

Related Videos
Ivo Carre, PhD, senior business analyst, Lifescience Dynamics
Antonio Urbina, MD
Tina Bhatnagar, DO
Peter Voorhees, MD, Atrium Health Levine Cancer Institute
Antonio Urbina, MD
Ciara Zachary, PhD, MPH
Hearn Jay Cho, MD, PhD
Nicoletta Colombo, MD, PhD
Eleanor Perfetto, PhD
Related Content
Prerna Mewawalla, MD

Redesigning Trials for Real-World Patient Complexity: A Q&A With Prerna Mewawalla, MD

December 4th 2025
Article

Prerna Mewawalla, MD, discusses innovative strategies to enhance cancer care access, reduce clinician burden, and improve clinical trial diversity in real-world settings.

Read More

Managed Care Cast

Frameworks for Advancing Health Equity: Dental Health Care Access

December 2nd 2025
Podcast

Explore innovative strategies in dental care that are enhancing access, promoting health equity, and improving community health in Pennsylvania.

Listen

AJMC Q&A with Svetlana Barbarash | Background image credit: ipopba – stock.adobe.com

Provider Shortages in Nevada Leave Gaps in Cardiovascular Care: Svetlana Barbarash, MD

November 25th 2025
Article

Svetlana Barbarash, MD, outlines the lack of cardiologists and transplant services in Las Vegas and the policy changes needed to close gender gaps in care.

Read More

Managed Care Cast Square thumbnail

Managed Care Cast Presents: New Evidence and Economic Considerations in IPF Care

November 25th 2025
Podcast

Experts discuss the clinical and economic burden of idiopathic pulmonary fibrosis (IPF), emerging clinical data, and strategies to improve patient outcomes.

Listen

Mark Lebwohl, MD

Urticaria Symptoms, Sleep Improve With Remibrutinib: Mark Lebwohl, MD

November 20th 2025
Article

Urticaria symptom reduction with remibrutinib was linked with improved quality of life and sleep for patients with chronic spontaneous urticaria.

Read More

Michael Palumbo, MD

Quick Responses May Boost Adherence to Remibrutinib in CSU: Michael J. Palumbo, MD

November 19th 2025
Article

Remibrutinib shows rapid and sustained relief for chronic spontaneous urticaria, offering a promising oral treatment option for patients.

Read More

© 2025 MJH Life Sciences
AJMC®
All rights reserved.